**Core Concept**
The **renin-angiotensin-aldosterone system (RAAS)** plays a crucial role in regulating blood pressure and fluid balance. **Plasma renin activity** is a measure of the enzyme renin's activity in the blood, which initiates the RAAS cascade.

**Why the Correct Answer is Right**
The correct answer choice would typically include drugs that directly or indirectly inhibit the release or action of renin, thereby lowering plasma renin activity. For example, **beta-blockers** can decrease renin release from the juxtaglomerular cells in the kidneys, thus lowering plasma renin activity.

**Why Each Wrong Option is Incorrect**
**Option A:** Would be incorrect if it included drugs that increase plasma renin activity, such as diuretics.
**Option B:** Might be incorrect if it involved drugs that have no direct effect on renin release or are actually part of the RAAS pathway.
**Option D:** Could be incorrect if it comprised drugs that stimulate renin release or enhance the effects of the RAAS.

**Clinical Pearl / High-Yield Fact**
A key point to remember is that **beta-blockers**, by reducing sympathetic stimulation to the juxtaglomerular cells, can decrease renin release and subsequently lower plasma renin activity, making them a potential correct answer choice in this context.

**Correct Answer:** **C. Beta-blockers.**